Israel Armando Guerra Cuyutupac

Israel Armando Guerra Cuyutupac

Auto-generated profile, based on publicly available information

Israel Armando Guerra Cuyutupac

Universidad Científica del Sur, Lima, Perú

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2022 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
EAEfrain A. Cehua Alvarez
Efrain A. Cehua Alvarez
JMJoseph Alburqueque Melgarejo
Joseph Alburqueque Melgarejo
HFHorus M. Viru Flores
Horus M. Viru Flores
JRJuan C. Roque-Quezada
Juan C. Roque-Quezada
CECatherine A. Suárez Egoávil
Catherine A. Suárez Egoávil
IGIsrarel A. Guerra
Israrel A. Guerra
Objective:To determine the factors associated with anxiety in medical interns at a private university in the context of the COVID-19 pandemic. Methods: The study design is quantitative, observational, analytical, retrospective, cross-sectional. The sample was composed of 343 human medicine interns, who were selected by a non-probabilistic snowball type sampling. The Coronavirus Anxiety Scale instrument was used for the diagnosis of anxiety. A Poisson regression model with robust bivariate and multiple variances was used to calculate the prevalence ratio and their respective 95% condence intervals. Results: The prevalence of anxiety and severe depressive symptoms of 22,74% and 6,71% respectively was found. Depressive symptoms aPR 3.27 (95% CI 1,06 - 10,09), having children aPR 2,61 (95% CI 1,26 - 5,38), and the diagnosis of COVID-19 in the last 12 months aPR 2,20 (95% CI 1,25 - 3,87) were associated with the presence of anxiety in the multiple regression model. Conclusions: The presence of severe depressive symptoms, having children, the diagnosis of COVID-19 in the last 12 months are associated with the diagnosis of anxiety in medical interns at a private university in Lima, 2021

29 April 2024 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
JMJoseph Alburqueque Melgarejo
Joseph Alburqueque Melgarejo
ICIsrael Armando Guerra Cuyutupac
Israel Armando Guerra Cuyutupac
JQJuan Carlos Ezequiel Roque Quezada
Juan Carlos Ezequiel Roque Quezada
HFHorus Michael Virú Flores
Horus Michael Virú Flores
MCMartha Eugenia Aguirre Coronado
Martha Eugenia Aguirre Coronado
MMMaster in Human Medicine
Master in Human Medicine
Introduction: SARS-CoV-2 infection can produce a hypercoagulable state and increase the risk of developing thrombotic events. Several observational studies have reported an association between D-dimer levels on admission and mortality from COVID-19. Objective: The objective of the present study was to determine the prognostic capacity of D-dimer in predicting mortality from COVID-19 in patients hospitalized in the Intensive Care Unit. Methods: An observational, analytical and retrospective cohort design was used. A sample size of 324 hospitalized patients was calculated, who were followed during the period January to July 2021 to evaluate the outcome of disease. For statistical analysis, the SPSS version 26 statistical package was used. Results: A cut-off point of 1.40 µg/mL was calculated for D-dimer values ​​with a sensitivity of 80.9%, a specificity of 86.4% and area under the curve (AUC) of 0.916 (CI 95%: 0.884 – 0.947; p =0.016) to predict mortality from COVID-19. Likewise, it was found that patients with D-dimer values ​​greater than or equal to 1.40 µg/mL had an increased risk of mortality in patients with COVID-19 (HRa = 6.545; 95% CI: 3.867 – 11.077; p<0.001), independent of the variables of age, diabetes mellitus, arterial hypertension, ischemic heart disease, cerebrovascular disease, atrial fibrillation, chronic obstructive pulmonary disease, asthma, cancer and thrombocytopenia. Conclusions: The present study showed that D-dimer levels on admission represent a reliable biomarker in the evaluation of the prognosis of patients with COVID-19. Resumen Introducción: La infección por SARS-CoV-2 puede producir un estado hipercoagulable e incrementar el riesgo de desarrollar eventos tromboticos. Varios estudios observacionales han reportado una asociación entre los niveles de dimero D al ingreso y la mortalidad por COVID-19. Objetivo: El objetivo del presente estudio fue determinar la capacidad pronostica del dimero D en la predicción de mortalidad por COVID-19 en pacientes hospitalizados en la Unidad de Cuidados Intensivos. Métodos: Se empleó un diseño observacional, analítico, y de tipo cohorte retrospectiva. Se calculó un tamaño muestral de 324 pacientes hospitalizados, los cuales fueron seguidos durante el periodo enero a julio del año 2021 para evaluar el descenlace de la enfermedad. Para el análisis estadistico se utilizó el paquete estadístico SPSS versión 26. Resultados: Se determinó un punto de corte de 1,40 µg/mL para los valores de dimero D con una sensibilidad de 80,9%, una especificidad de 86,4% y área bajo la curva (AUC) de 0,916 (IC 95%: 0,884 – 0,947; p =0,016) para predecir mortalidad por COVID-19. Asimismo, se encontró que pacientes con valores de dimero D mayores o iguales a 1,40 µg/mL tenian un riesgo incrementado de fallecimiento en pacientes con COVID-19 (HRa = 6,545; IC 95%: 3,867 – 11,077; p<0,001), independientemente de las variables edad, diabetes mellitus, hipertensión arterial, cardiopatía isquémica, enfermedad cerebrovascular, fibrilación auricular, enfermedad pulmonar obstructiva crónica, asma, cáncer y trombocitopenia. Conclusiones: El presente estudio mostró que los niveles de dimero D al ingreso representan un biomarcador fiable en la evaluación del pronostico de pacientes con COVID-19.

11 September 2020 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
ICIsrael Armando Guerra Cuyutupac
Israel Armando Guerra Cuyutupac
Objectives: To determine the prevalence of helicobacter pylori in dental biofilm in patients with chronic gastritis in the gastroenterology service of Hospital María Helper. Methods: A cross-sectional descriptive observational study was carried out, working with a population of patients attended in 1 calendar year, of the of which only 100 patients met the inclusion and exclusion criteria. It has been made a collection for the variables age, sex, helicobacter pylori in dental biofilm and helicobacter pylori in gastric mucosa biopsy. The relative frequency of Helicobacter Pylori in dental biofilm in patients with chronic gastritis and so exploratory a chi2-square test was performed for helicobacter in dental biofilm and helicobacter in gastric mucosa biopsy. Results: A prevalence of helicobacter pylori was detected in dental biofilm from 66% in patients with chronic gastritis, in turn 48% of the total in this group I present a positive helicobacter pylori in gastric mucosa biopsy. From the patients positive for helicobacter pylori in gastric mucosa 83.33% presented positivity in dental biofilm. An association was found for the variables helicobacter pylori in dental biofilm and helicobacter pylori in gastric mucosa biopsy with a p value = 0.002. Conclusions: A high prevalence of helicobacter pylori was found in biofilm of patients with chronic gastritis and an association between dental biofilm and gastric mucosa biopsy for helicobacter pylori.